AbbVie (ABBV) Exchange Rate Effect (2013 - 2026)

AbbVie (ABBV) has reported Exchange Rate Effect for 14 consecutive years, with -$7.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Exchange Rate Effect fell 123.33% year-over-year to -$7.0 million in Q2 2026; TTM through Jun 2026 was -$16.0 million, a 1700.0% decrease from a year earlier, with the FY2025 full-year figure at $42.0 million, up 164.62% from the prior year.
• Exchange Rate Effect was -$7.0 million for Q2 2026 at AbbVie, up from -$12.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $30.0 million in Q2 2025 and troughed at -$59.0 million in Q3 2022.
• A 5-year average of -$5.5 million and a median of -$7.5 million in 2025 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect tumbled 325.0% in 2024 and jumped 433.33% in 2025, its largest moves.
• Over 5 years, Exchange Rate Effect stood at $23.0 million in 2022, then changed by 0.0% to $23.0 million in 2023, then slumped by 300.0% to -$46.0 million in 2024, then soared by 123.91% to $11.0 million in 2025, then sank by 163.64% to -$7.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$7.0 million (Q2 2026), -$12.0 million (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.